MARTELL RON 4
4 · Jasper Therapeutics, Inc. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
MARTELL RON
DirectorPresident, CEO and Director
Transactions
- Award
Stock Option (right to buy)
2022-03-21+1,704,328→ 1,704,328 totalExercise: $3.54Exp: 2032-03-21→ Common Stock (1,704,328 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on March 15, 2023, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.